PL430175A1 - Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria - Google Patents

Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria

Info

Publication number
PL430175A1
PL430175A1 PL430175A PL43017519A PL430175A1 PL 430175 A1 PL430175 A1 PL 430175A1 PL 430175 A PL430175 A PL 430175A PL 43017519 A PL43017519 A PL 43017519A PL 430175 A1 PL430175 A1 PL 430175A1
Authority
PL
Poland
Prior art keywords
escherichia coli
production
preparations
pathogenic bacteria
bacteriophage strains
Prior art date
Application number
PL430175A
Other languages
Polish (pl)
Other versions
PL241130B1 (en
Inventor
Marta Kuźmińska-Bajor
Maciej Kuczkowski
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL430175A priority Critical patent/PL241130B1/en
Publication of PL430175A1 publication Critical patent/PL430175A1/en
Publication of PL241130B1 publication Critical patent/PL241130B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Wynalazek dotyczy nowego szczepu bakteriofaga specyficznego wobec bakterii należących do gatunku Escherichia coli, wybranego ze szczepów zdeponowanych w Polskiej Kolekcji Mikroorganizmów pod numerami depozytowymi: F/00119, F/00120, F/00121, F/00122. Wynalazek dotyczy także zastosowanie szczepu bakteriofaga, wybranego ze szczepów zdeponowanych w Polskiej Kolekcji Mikroorganizmów pod wskazanymi numerami, do wytwarzania preparatów przeciwbakteryjnych, służących do zwalczania bakterii Escherichia coli.The invention relates to a new bacteriophage strain specific for bacteria belonging to the species Escherichia coli, selected from the strains deposited in the Polish Microbial Collection under the deposit numbers: F / 00119, F / 00120, F / 00121, F / 00122. The invention also relates to the use of a bacteriophage strain selected from the strains deposited in the Polish Collection of Microorganisms under the numbers indicated, for the production of antibacterial preparations for the control of Escherichia coli.

PL430175A 2019-06-07 2019-06-07 Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria PL241130B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL430175A PL241130B1 (en) 2019-06-07 2019-06-07 Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL430175A PL241130B1 (en) 2019-06-07 2019-06-07 Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria

Publications (2)

Publication Number Publication Date
PL430175A1 true PL430175A1 (en) 2020-12-14
PL241130B1 PL241130B1 (en) 2022-08-08

Family

ID=73727730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL430175A PL241130B1 (en) 2019-06-07 2019-06-07 Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria

Country Status (1)

Country Link
PL (1) PL241130B1 (en)

Also Published As

Publication number Publication date
PL241130B1 (en) 2022-08-08

Similar Documents

Publication Publication Date Title
MX2018009539A (en) Use of microbial communities for human and animal health.
AR113011A1 (en) BACTERIAL EXTRACELLULAR VESICULES
MX2018012553A (en) Methods for improving agricultural production of fowl by administration of microbial consortia or purified strains thereof.
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
WO2008111719A8 (en) Bacillus amyloliquefaciens k317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism
WO2019018499A3 (en) Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
RS20180250A1 (en) Bacterial strain bacillus amyloliquefaciens subsp. plantarium bs89 as agent for increasing productivity of plants and protecting same from diseases
EP3574900A8 (en) New applications of rifamycin-nitroimidazole coupling molecules
WO2022038365A3 (en) Fumarate derivatives and their medical use
MX2023012436A (en) Improving fowl production by administration of a synthetic bioensemble of microbes or purified strains thereof.
WO2018004224A3 (en) Novel sporichthyaceae microorganism and use thereof
EP4039794A4 (en) Staphylococcus epidermidis strain having immunity-enhancing activity and antibacterial activity against pathogenic bacteria, and use thereof
BR112021015638A2 (en) Methods, compositions containing bacillus-producing bacteria or preparations thereof
PL430175A1 (en) Bacteriophage strains specific for Escherichia coli and their use in production of preparations for combating pathogenic bacteria
MX2022005064A (en) Serotonin producing bacteria.
PL430168A1 (en) Strains of bacteriophages specific for bacteria belonging to the Salmonella genus and their use in the production of preparations against pathogenic bacteria
RU2012148482A (en) STRAIN OF BACTERIA Escherichia coli - PRODUCER OF RECOMBINANT FLAGELLIN
WO2019211635A8 (en) Antimicrobial composition and the use of thereof
MX2023012704A (en) Bacterial strains having fungicidal activity, compositions comprising same and use thereof.
RU2013151377A (en) A STRAIN of BACTERIUS subtilis BACTERIA FOR PRODUCING A BIOLOGICAL PRODUCT AGAINST PHYTOPATHOGENIC MUSHROOMS
PL412829A1 (en) New grafts of bacteriofages, specific to bacteria belonging to Staphylococcus genus and their application in production of the preparations fighting bacterial infections
PL412828A1 (en) New grafts of bacteriofages, specific to bacteria belonging to Pseudomonas genus and their application in production of the preparations fighting bacterial infections
WO2020109567A8 (en) Increased bioactivity of bioprotective cultures against pathogenic bacteria
PL435199A1 (en) Bacteriophage composition specific for Enterobacterlaceae, in particular Escherichia coli, use of the bacteriophage composition for treatment of infections caused by Enterobacterlaceae, in particular Escherichia coli, and use of the bacteriophage composition as a biocontrol factor
PL413052A1 (en) Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains